Literature DB >> 14593729

Dynamics of the mitotic spindle--potential therapeutic targets.

David T Miyamoto1, Zachary E Perlman, Timothy J Mitchison, Mimi Shirasu-Hiza.   

Abstract

Inhibition of mitosis is a useful strategy for treating diseases involving excessive cell proliferation. Antimitotic drugs currently in clinical use perturb microtubule dynamics and thereby disrupt the function of the mitotic spindle. Protein regulators of microtubule dynamics and microtubule motors are also essential for mitotic spindle function. In this chapter, we evaluate the potential of these proteins as candidate targets for antimitotic drugs. We review in depth a number of proteins of particular interest, highlighting their known functions in mitosis and the effects of their inhibition on cell cycle progression.

Mesh:

Substances:

Year:  2003        PMID: 14593729

Source DB:  PubMed          Journal:  Prog Cell Cycle Res        ISSN: 1087-2957


  5 in total

1.  Monastrol inhibition of the mitotic kinesin Eg5.

Authors:  Jared C Cochran; Joseph E Gatial; Tarun M Kapoor; Susan P Gilbert
Journal:  J Biol Chem       Date:  2005-01-23       Impact factor: 5.157

Review 2.  Resistance to anti-tubulin agents: From vinca alkaloids to epothilones.

Authors:  Werner Krause
Journal:  Cancer Drug Resist       Date:  2019-03-19

3.  NSC 622124 inhibits human Eg5 and other kinesins via interaction with the conserved microtubule-binding site.

Authors:  Sarah S Learman; Catherine D Kim; Nathaniel S Stevens; Sunyoung Kim; Edward J Wojcik; Richard A Walker
Journal:  Biochemistry       Date:  2009-03-03       Impact factor: 3.162

4.  Kinesin-5 motors are required for organization of spindle microtubules in Silvetia compressa zygotes.

Authors:  Nick T Peters; Darryl L Kropf
Journal:  BMC Plant Biol       Date:  2006-08-31       Impact factor: 4.215

5.  A microtubule interactome: complexes with roles in cell cycle and mitosis.

Authors:  Julian R Hughes; Ana M Meireles; Katherine H Fisher; Angel Garcia; Philip R Antrobus; Alan Wainman; Nicole Zitzmann; Charlotte Deane; Hiroyuki Ohkura; James G Wakefield
Journal:  PLoS Biol       Date:  2008-04-22       Impact factor: 8.029

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.